Myopridin 3 mg, Tabletten

7680700450010 CH-70045 Tabletten

Associated product:

MYOPRIDIN 3 mg cpr 20 pce

No image available

Article details

Package size
20
Selling units
20
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/10/2026
Patient information leaflet
Français
07/10/2026
Patient information leaflet
Italien
07/10/2026
Summary of Product Characteristics
Allemand
06/10/2026
Summary of Product Characteristics
Français
06/10/2026
Summary of Product Characteristics
Italien
06/10/2026

Detailed composition

Substance Quantity Type Category
pridinolum
3.02 MG Substance Wirkstoff (Principe actif)
pridinoli mesilas
- Substance WIZUS
lactosum monohydricum
- Substance HNIDK
lactosum
143.5 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
ricini oleum hydrogenatum
- Substance HNIDK
talcum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Authorization holder

Dermapharm AG

6331 Hünenberg

Authorization information

Swissmedic authorization number
70045
Drug name
Myopridin 3 mg, Tabletten
Galenic form
TAB
ATC Code
M03BX03
Authorization status
Z
Dispensing category
B
First authorization
26/01/2026
Authorization expiration date
25/01/2031
IT Number
01.12.0.
Domain
Human medicine
Field of application
Zentrale und periphere Muskelspasmen bei Erwachsenen

Package details

Description (FR)
MYOPRIDIN 3 mg cpr 20 pce
Description (DE)
MYOPRIDIN 3 mg Tabl 20 Stk
Market launch
08/10/2026
Narcotic (BTM)
No

Other package sizes (1)

MYOPRIDIN 3 mg cpr 50 pce
50 TABL
GTIN: 7680700450027
View
Buy us a coffee Explore the data